Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 20.24
-0.75 (-3.57%)
May 12, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 8.35 billion as of May 12, 2026. Its market cap has decreased by -8.25% in one year.
Market Cap
8.35B
Enterprise Value
6.41B
Revenue
1.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
20.24
Market Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 8.35B, a decrease of -75.55%. That is a compound annual growth rate of -26.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 8.05B | 1.10% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangxi Fushine Pharmaceutical | 9.37B |
| Aurisco Pharmaceutical | 9.13B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 9.00B |
| Sino Biological,Inc. | 8.98B |
| Zhejiang Ausun Pharmaceutical | 8.55B |
| Shanghai Medicilon | 8.55B |
| GemPharmatech | 8.54B |
| Bio-Thera Solutions | 8.43B |